HRAS

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, HRAS mutation is significantly associated with the RNA expression of many other genes, with 6,460 significant associations in total. THCA shows the largest number of these associations.

The most reproducible HRAS-associated genes across cancer lineages are LRRFIP2, FHOD3, and PARP8. Each is linked with HRAS in more than 4 cancer types. Because this analysis shows association rather than direction, both HRAS-to-partner and partner-to-HRAS results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, LRRFIP2 grouped by HRAS-low versus HRAS-high in HNSC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (HRAS→partner) and Y-score (partner→HRAS) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
HNSCLRRFIP2 →+0.520+3.392<.001<.00135
HNSCFHOD3 →+0.885+2.932<.001<.00134
HNSCPARP8 →+0.565+3.482<.001.00234
THCAACOT11 →+0.593+4.028<.001<.00134
THCALMNTD2 →+0.479+3.339.006.00534
THYMPWRN4 →+0.356+3.485<.001.00534
Each partner links to its Q-omics profile. Showing the 6 strongest of 6,460 associations by consensus.

LRRFIP2 by HRAS expression — HNSC

Box plot of LRRFIP2 in HRAS-low vs HRAS-high samples in HNSC.

Explore this box plot interactively →

Exploration